聚合物微囊的可逆透纳米膜
Andre G Skirtach1, Peter Karageorgiev, Matthieu F Bédard
1Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14424 Potsdam, Germany. skitach@mpikg.mpg.de
Journal of the American Chemical Society
|August 8, 2008
概括
研究人员使用金纳米粒子开发了可光控制的纳米膜. 这些膜在激光照明时可逆地改变透性,为控制细胞过程提供了新的可能性.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 生物物理学的生物物理.
背景情况:
- 聚合物膜在各种应用中至关重要,但动态控制其透性仍然是一个挑战.
- 现有的透控制方法往往缺乏可逆性或需要复杂的外部刺激.
- 纳米材料为开发先进的膜技术提供了独特的特性.
研究的目的:
- 提供可光控制的聚合物纳米膜,具有可调节的透性.
- 通过使用光敏感纳米粒子,展示一种可逆透性控制的新机制.
- 探索这些纳米膜在诸如细胞内信号传输等领域的潜在应用.
主要方法:
- 制造纳米厚的聚合物膜.
- 将金纳米粒子聚合物作为光活性中心的结合.
- 在透性研究中使用微囊作为模型膜系统.
- 采用激光照明来诱导膜透性的可逆变化.
主要成果:
- 在激光照射暴露后,纳米膜透性的可逆变化得到证明.
- 展示了金纳米颗粒能够暂时改变附近的聚合物网络的能力.
- 证实,当照明停止时,纳米膜会恢复到它们的不透状态.
- 验证了微囊系统作为可光控制膜模型的有效性.
结论:
- 开发了一种新且简单的方法,用于控制纳米膜的可逆透性.
- 可光控制的纳米膜为光驱应用提供了一个有前途的平台.
- 该技术在细胞内信号传输和先进的膜设计中具有重要的应用潜力.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...


